P, L., AF, C., SY, C., JS, S., T, K., O, S., . . . P, M. (2018). Predictors of visual outcomes in patients with neovascular age-related macular degeneration treated with anti-vascular endothelial growth factor therapy: Post hoc analysis of the VIEW studies. Acta ophthalmologica, 96(8), e911. https://doi.org/10.1111/aos.13751
Chicago Style (17th ed.) CitationP, Lanzetta, Cruess AF, Cohen SY, Slakter JS, Katz T, Sowade O, Zeitz O, Ahlers C, and Mitchell P. "Predictors of Visual Outcomes in Patients with Neovascular Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor Therapy: Post Hoc Analysis of the VIEW Studies." Acta Ophthalmologica 96, no. 8 (2018): e911. https://doi.org/10.1111/aos.13751.
MLA (9th ed.) CitationP, Lanzetta, et al. "Predictors of Visual Outcomes in Patients with Neovascular Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor Therapy: Post Hoc Analysis of the VIEW Studies." Acta Ophthalmologica, vol. 96, no. 8, 2018, p. e911, https://doi.org/10.1111/aos.13751.